Literature DB >> 16885229

Prefibrillar amyloid aggregates could be generic toxins in higher organisms.

Serena Baglioni1, Fiorella Casamenti, Monica Bucciantini, Leila M Luheshi, Niccolò Taddei, Fabrizio Chiti, Christopher M Dobson, Massimo Stefani.   

Abstract

More than 40 human diseases are associated with fibrillar deposits of specific peptides or proteins in tissue. Amyloid fibrils, or their precursors, can be highly toxic to cells, suggesting their key role in disease pathogenesis. Proteins not associated with any disease are able to form oligomers and amyloid assemblies in vitro displaying structures and cytotoxicity comparable with those of aggregates of disease-related polypeptides. In isolated cells, such toxicity has been shown to result from increased membrane permeability with disruption of ion homeostasis and oxidative stress. Here we microinjected into the nucleus basalis magnocellularis of rat brains aggregates of an Src homology 3 domain and the N-terminal domain of the prokaryotic HypF, neither of which is associated with amyloid disease. Prefibrillar aggregates of both proteins, but not their mature fibrils or soluble monomers, impaired cholinergic neuron viability in a dose-dependent manner similar to that seen in cell cultures. Contrary to the situation with cultured cells, however, under our experimental conditions, cell stress in tissue is not followed by a comparable level of cell death, a result that is very likely to reflect the presence of protective mechanisms reducing aggregate toxicity. These findings support the hypothesis that neurodegenerative disorders result primarily from a generic cell dysfunction caused by early misfolded species in the aggregation process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16885229      PMCID: PMC6673784          DOI: 10.1523/JNEUROSCI.4809-05.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  80 in total

1.  Effects of peptides derived from terminal modifications of the aβ central hydrophobic core on aβ fibrillization.

Authors:  Cyrus K Bett; Wilson K Serem; Krystal R Fontenot; Robert P Hammer; Jayne C Garno
Journal:  ACS Chem Neurosci       Date:  2010-08-26       Impact factor: 4.418

2.  Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure.

Authors:  Robin Altman; Sonny Ly; Silvia Hilt; Jitka Petrlova; Izumi Maezawa; Tamás Kálai; Kálmán Hideg; Lee-Way Jin; Ted A Laurence; John C Voss
Journal:  Biochim Biophys Acta       Date:  2015-09-14

3.  Role of Species-Specific Primary Structure Differences in Aβ42 Assembly and Neurotoxicity.

Authors:  Robin Roychaudhuri; Xueyun Zheng; Aleksey Lomakin; Panchanan Maiti; Margaret M Condron; George B Benedek; Gal Bitan; Michael T Bowers; David B Teplow
Journal:  ACS Chem Neurosci       Date:  2015-10-19       Impact factor: 4.418

4.  Studying polyglutamine aggregation in Caenorhabditis elegans using an analytical ultracentrifuge equipped with fluorescence detection.

Authors:  Bashkim Kokona; Carrie A May; Nicole R Cunningham; Lynn Richmond; F Jay Garcia; Julia C Durante; Kathleen M Ulrich; Christine M Roberts; Christopher D Link; Walter F Stafford; Thomas M Laue; Robert Fairman
Journal:  Protein Sci       Date:  2015-12-21       Impact factor: 6.725

5.  Protein folding: then and now.

Authors:  Yiwen Chen; Feng Ding; Huifen Nie; Adrian W Serohijos; Shantanu Sharma; Kyle C Wilcox; Shuangye Yin; Nikolay V Dokholyan
Journal:  Arch Biochem Biophys       Date:  2007-06-08       Impact factor: 4.013

Review 6.  Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders.

Authors:  F Rahimi; A Shanmugam; G Bitan
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

Review 7.  Structural classification of toxic amyloid oligomers.

Authors:  Charles G Glabe
Journal:  J Biol Chem       Date:  2008-08-22       Impact factor: 5.157

Review 8.  Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.

Authors:  Tessa Sinnige; Anan Yu; Richard I Morimoto
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

9.  The mechanism of membrane disruption by cytotoxic amyloid oligomers formed by prion protein(106-126) is dependent on bilayer composition.

Authors:  Patrick Walsh; Gillian Vanderlee; Jason Yau; Jody Campeau; Valerie L Sim; Christopher M Yip; Simon Sharpe
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

10.  Acridine derivatives inhibit lysozyme aggregation.

Authors:  Zuzana Gazova; Andrea Bellova; Zuzana Daxnerova; Jan Imrich; Pavol Kristian; Jana Tomascikova; Jaroslava Bagelova; Diana Fedunova; Marian Antalik
Journal:  Eur Biophys J       Date:  2008-04-03       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.